...
机译:1p染色体状态对少突胶质瘤对替莫唑胺反应的影响:初步结果
Department of Neurological Surgery Brain Tumor Institute Cleveland Clinic Cancer Center Cleveland Clinic;
Department of Neurological Surgery Brain Tumor Institute Cleveland Clinic Cancer Center Cleveland Clinic;
Department of Hematology/Oncology Brain Tumor Institute Cleveland Clinic Cancer Center Cleveland Clinic;
Department of Anatomic Pathology Brain Tumor Institute Cleveland Clinic Cancer Center Cleveland Clinic;
Department of Biostatistics Brain Tumor Institute Cleveland Clinic Cancer Center Cleveland Clinic;
Department of Neurological Surgery Brain Tumor Institute Cleveland Clinic Cancer Center Cleveland Clinic;
oligodendroglioma; allelic loss 1p; temozolomide; chemotherapy; molecular genetics;
机译:少突胶质细胞瘤对替莫唑胺反应中1p染色体状态的影响:初步结果。
机译:间变性和复发性少突胶质细胞瘤中O6-甲基鸟嘌呤DNA甲基转移酶启动子甲基化状态,1p和19q缺失与替莫唑胺反应的相关性:前瞻性GICNO研究。
机译:替莫唑胺作为成人低级少突胶质细胞瘤或少突星形细胞瘤的初始治疗,并与1p号染色体缺失相关。
机译:染色体1P / 19Q型较低级胶质瘤中MRI基辐射瘤的开发和验证染色体1P / 19Q共缺失的非侵袭性基因型预测
机译:阅读障碍和注意力缺陷多动障碍的遗传关联研究,其候选区域位于6p号染色体上,而一个基因位于1p号染色体上
机译:追溯确定新诊断的1p / 19q共删除的无胶状树突神经胶质瘤患者中PCV与temozolomoide等效性的at-27挑战
机译:低级胶质瘤的替莫唑啉代:1P / 19Q对响应和结果的预测影响